drug discovery Archives | EMBL
EMBL and Tara: Hamburg
EMBL Hamburg and Tara raise awareness of the risks of microplastic pollution and global infection
Prioritising cancer drug targets using CRISPR
Large CRISPR screen prioritises hundreds of promising genes for personalised cancer treatment
New Open Targets Director appointed
New director drives drug discovery partnership forward
Sanofi joins Open Targets
Pharmaceutical company Sanofi strengthens drug targets discovery collaboration Open Targets
Promega joins EMBL’s Corporate Partnership Programme
EMBL and Promega collaborate to train young scientists
Celgene joins Open Targets
New partner strengthens drug discovery collaboration
Futures: Unravelling influenza
ERC grantee Stephen Cusack shares his vision for the next ten years
Takeda joins drug target discovery initiative
Takeda joins pioneering public-private drug discover collaboration Open Targets
Fighting disease with structural biology
Alumnus Michael Parker talks about his career, research highlights and how EMBL has played a role
Welcome, Andrew Leach
Q&A with EMBL-EBI's Head of Chemical Biology data services
